# OnCo record ev-pembro-continuum (pairing). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/pairings/ev-pembro-continuum/>
  a schema:MedicalTherapy ;
  onco:kind "pairing" ;
  schema:identifier "ev-pembro-continuum" ;
  schema:name "Enfortumab vedotin + pembrolizumab across the bladder cancer continuum"@en ;
  schema:description "The ADC-immunotherapy pair that doubled survival in advanced disease now also works around surgery, in fit and unfit patients alike."@en ;
  schema:url <https://onco.cc/pairings/ev-pembro-continuum/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04223856>, <https://clinicaltrials.gov/study/NCT03924895> ;
  onco:cancers <https://onco.cc/cancers/urothelial/> ;
  onco:drugs <https://onco.cc/drugs/enfortumab-vedotin/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:trials <https://onco.cc/trials/ev-302/>, <https://onco.cc/trials/ev-303/>, <https://onco.cc/trials/ev-304/> ;
  onco:pairs <https://onco.cc/drugs/enfortumab-vedotin/>, <https://onco.cc/drugs/pembrolizumab/> .
